Trial intelligence / Profile preview

Levosimendan vs Milrinone in Infants After Open Heart Surgery

NCT00549107Phase 2Unknown

Sponsor
Ludwig Boltzmann Gesellschaft
Start
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of levosimendan in low cardiac output syndrome (LCOS), sponsored by Ludwig Boltzmann Gesellschaft. Status: unknown.

02

Drugs

levosimendan
03

Conditions

low cardiac output syndrome (LCOS)

Beyond the preview

Go deeper on NCT00549107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00549107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call